The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Abstract:

:Chronic myeloid leukemia is effectively treated with imatinib, but reactivation of BCR-ABL frequently occurs through acquisition of kinase domain mutations. The additional approved ABL tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib, along with investigational TKIs such as ponatinib (AP24534) and DCC-2036, support the possibility that mutation-mediated resistance in chronic myeloid leukemia can be fully controlled; however, the molecular events underlying resistance in patients lacking BCR-ABL point mutations are largely unknown. We previously reported on an insertion/truncation mutant, BCR-ABL(35INS), in which structural integrity of the kinase domain is compromised and all ABL sequence beyond the kinase domain is eliminated. Although we speculated that BCR-ABL(35INS) is kinase-inactive, recent reports propose this mutant contributes to ABL TKI resistance. We present cell-based and biochemical evidence establishing that BCR-ABL(35INS) is kinase-inactive and does not contribute to TKI resistance, and we find that detection of BCR-ABL(35INS) does not consistently track with or explain resistance in clinical samples from chronic myeloid leukemia patients.

journal_name

Blood

journal_title

Blood

authors

O'Hare T,Zabriskie MS,Eide CA,Agarwal A,Adrian LT,You H,Corbin AS,Yang F,Press RD,Rivera VM,Toplin J,Wong S,Deininger MW,Druker BJ

doi

10.1182/blood-2011-05-349191

subject

Has Abstract

pub_date

2011-11-10 00:00:00

pages

5250-4

issue

19

eissn

0006-4971

issn

1528-0020

pii

blood-2011-05-349191

journal_volume

118

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum.

    abstract::IL-15 is an important cytokine for the function of the immune system, but the form(s) of IL-15 produced in the human body are not fully characterized. Coexpression of the single-chain IL-15 and the IL-15 receptor alpha (IL-15Rα) in the same cell allows for efficient production, surface display, and eventual cleavage a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-384362

    authors: Bergamaschi C,Bear J,Rosati M,Beach RK,Alicea C,Sowder R,Chertova E,Rosenberg SA,Felber BK,Pavlakis GN

    更新日期:2012-07-05 00:00:00

  • A site involving the "hybrid" and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia.

    abstract::Drug-dependent antibodies (DDAbs) can cause the precipitous destruction of platelets if a patient is exposed to the drug for which the antibodies are specific. The molecular character of the epitopes recognized is poorly understood, and the mechanism by which drugs promote tight binding of these antibodies to platelet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2336

    authors: Peterson JA,Nyree CE,Newman PJ,Aster RH

    更新日期:2003-02-01 00:00:00

  • Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia.

    abstract::The relationship between the level of retinoblastoma protein (RB) expression and the survival of 113 newly diagnosed acute myelogenous leukemia (AML) patients was studied. Western blotting was used to determine the level of RB protein present in peripheral blood leukemia cells and results were confirmed in 26 patients...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kornblau SM,Xu HJ,Zhang W,Hu SX,Beran M,Smith TL,Hester J,Estey E,Benedict WF,Deisseroth AB

    更新日期:1994-07-01 00:00:00

  • DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells.

    abstract::The Y chromosome encodes male-specific minor histocompatibility (H-Y) antigens that stimulate T- and B-lymphocyte responses after sex-mismatched allogeneic hematopoietic cell transplantation (HCT). A CD8(+) cytotoxic T lymphocyte (CTL) clone that recognizes a novel HLA-B*2705-restricted H-Y antigen encoded by the DDX3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-096313

    authors: Rosinski KV,Fujii N,Mito JK,Koo KK,Xuereb SM,Sala-Torra O,Gibbs JS,Radich JP,Akatsuka Y,Van den Eynde BJ,Riddell SR,Warren EH

    更新日期:2008-05-01 00:00:00

  • High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.

    abstract::In lymphatic tissues, chronic lymphocytic leukemia (CLL) cells are interspersed with CD68(+) nurselike cells (NLCs), T cells, and other stromal cells that constitute the leukemia microenvironment. However, the mechanism regulating colocalization of CLL and these accessory cells are largely unknown. To dissect the mole...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-170415

    authors: Burger JA,Quiroga MP,Hartmann E,Bürkle A,Wierda WG,Keating MJ,Rosenwald A

    更新日期:2009-03-26 00:00:00

  • Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.

    abstract::c-MYC inhibits differentiation and regulates the process by which cells acquire biomass, cell growth. Down-regulation of c-MYC, reduced cell growth, and decreased activity of the PI3K/AKT/mTORC1 signal transduction pathway are features of the terminal differentiation of committed myeloid precursors to polymorphonuclea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-111856

    authors: Wall M,Poortinga G,Hannan KM,Pearson RB,Hannan RD,McArthur GA

    更新日期:2008-09-15 00:00:00

  • STIM1 is essential for Fcgamma receptor activation and autoimmune inflammation.

    abstract::Fcgamma receptors (FcgammaRs) on mononuclear phagocytes trigger autoantibody and immune complex-induced diseases through coupling the self-reactive immunoglobulin G (IgG) response to innate effector pathways, such as phagocytosis, and the recruitment of inflammatory cells. FcRgamma-based activation is critical in the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-158477

    authors: Braun A,Gessner JE,Varga-Szabo D,Syed SN,Konrad S,Stegner D,Vögtle T,Schmidt RE,Nieswandt B

    更新日期:2009-01-29 00:00:00

  • Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.

    abstract::The ex vivo expansion of hematopoietic progenitors is a promising approach for accelerating the engraftment of recipients, particularly when cord blood (CB) is used as a source of hematopoietic graft. With the aim of defining the in vivo repopulating properties of ex vivo-expanded CB cells, purified CD34(+) cells were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guenechea G,Segovia JC,Albella B,Lamana M,Ramírez M,Regidor C,Fernández MN,Bueren JA

    更新日期:1999-02-01 00:00:00

  • p53 at the crossroads of MPN treatment.

    abstract::In this issue of Blood, Lu et al describe the cooperation between an orally bioavailable mouse double minute 2 (MDM2) antagonist (RG7112) and the pegylated interferon α (Peg-IFNα 2a) to target JAK2V617F hematopoietic progenitors and stem cells. Their work provides a rationale for the treatment of patients suffering fr...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-06-579623

    authors: Plo I

    更新日期:2014-07-31 00:00:00

  • Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy.

    abstract::Autologous T cells engineered to express a CD19-specific chimeric antigen receptor (CAR) have produced impressive minimal residual disease-negative (MRD-negative) complete remission (CR) rates in patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, the factors associated with durable...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-11-883710

    authors: Hay KA,Gauthier J,Hirayama AV,Voutsinas JM,Wu Q,Li D,Gooley TA,Cherian S,Chen X,Pender BS,Hawkins RM,Vakil A,Steinmetz RN,Schoch G,Chapuis AG,Till BG,Kiem HP,Ramos JD,Shadman M,Cassaday RD,Acharya UH,Riddell SR

    更新日期:2019-04-11 00:00:00

  • RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection.

    abstract::While the interferon (IFN)-inducible double-stranded RNA (dsRNA)-dependent protein kinase PKR is reported to initiate apoptosis in some instances, the mechanism by which diverse stress stimuli activate PKR remains unknown. Now we report that RAX, the only known cellular activator for PKR, initiates PKR activation in r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-11-006817

    authors: Bennett RL,Blalock WL,Abtahi DM,Pan Y,Moyer SA,May WS

    更新日期:2006-08-01 00:00:00

  • Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.

    abstract::Heparin-induced thrombocytopenia/thrombosis (HIT/T) is a common complication of heparin therapy that is caused by antibodies to platelet factor 4 (PF4) complexed with heparin. The immune response is polyclonal and polyspecific, ie, more than one neoepitope on PF4 is recognized by HIT/T antibodies. One such epitope has...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1230

    authors: Li ZQ,Liu W,Park KS,Sachais BS,Arepally GM,Cines DB,Poncz M

    更新日期:2002-02-15 00:00:00

  • Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progenitor cells from patients with acute myeloid leukemia.

    abstract::Efflux of Hoechst 33342 from normal hematopoietic cells identifies a "side population" (SP(+)) of negatively staining cells that, in the mouse, are largely CD34(-) and are enriched for primitive progenitors. To further characterize human SP(+) cells, blood or bone marrow from 16 patients with acute myeloid leukemia (A...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.12.3882

    authors: Feuring-Buske M,Hogge DE

    更新日期:2001-06-15 00:00:00

  • Novel collectin/C1q receptor mediates mast cell activation and innate immunity.

    abstract::Mast cells play a critical role in innate immunity, allergy, and autoimmune diseases. The receptor/ligand interactions that mediate mast cell activation are poorly defined. The alpha2beta1 integrin, a receptor for collagens, laminins, decorin, E-cadherin, matrix metalloproteinase-1 (MMP-1), endorepellin, and several v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2218

    authors: Edelson BT,Stricker TP,Li Z,Dickeson SK,Shepherd VL,Santoro SA,Zutter MM

    更新日期:2006-01-01 00:00:00

  • Differential surrogate light chain expression governs B-cell differentiation.

    abstract::Surrogate light chain expression during B lineage differentiation was examined by using indicator fluorochrome-filled liposomes in an enhanced immunofluorescence assay. Pro-B cells bearing surrogate light chain components were found in mice, but not in humans. A limited subpopulation of relatively large pre-B cells in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.7.2459

    authors: Wang YH,Stephan RP,Scheffold A,Kunkel D,Karasuyama H,Radbruch A,Cooper MD

    更新日期:2002-04-01 00:00:00

  • Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10).

    abstract::An unbalanced translocation der(1;7)(q10; p10) is a nonrandom chromosomal aberration commonly observed in myelodysplastic syndrome and acute myeloid leukemia. We molecularly analyzed the breakpoints of der(1;7)(q10;p10) by quantitative fluorescent in situ hybridization (FISH) analyses using centromeric satellite DNAs ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0031

    authors: Wang L,Ogawa S,Hangaishi A,Qiao Y,Hosoya N,Nanya Y,Ohyashiki K,Mizoguchi H,Hirai H

    更新日期:2003-10-01 00:00:00

  • Effects of interleukin-2 on gene expression in human neutrophils.

    abstract::Recently, the interleukin-2 receptor (IL-2R) was shown to be present on human neutrophils, and IL-2-neutrophil interactions are believed to be important in both tumor rejection and increased susceptibility to bacterial infections. Furthermore, neutrophils have been shown to synthesize host defense proteins, such as cy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girard D,Gosselin J,Heitz D,Paquin R,Beaulieu AD

    更新日期:1995-08-01 00:00:00

  • Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

    abstract::In utero hematopoietic stem cell transplantation (IUHSCTx) can achieve mixed hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning or immunosuppression. The primary limitation to the clinical application of IUHSCTx has been minimal donor cell engraftment, well below therapeutic levels...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0016

    authors: Hayashi S,Peranteau WH,Shaaban AF,Flake AW

    更新日期:2002-08-01 00:00:00

  • The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects.

    abstract::1-deamino-8-d-arginine vasopressin (desmopressin [DDAVP]) is clinically efficacious in patients with mild platelet function disorders but it is not known which mechanisms mediate this effect. Our aim was to evaluate the impact of in vivo DDAVP administration in these patients. We assessed von Willebrand factor (VWF), ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-497123

    authors: Colucci G,Stutz M,Rochat S,Conte T,Pavicic M,Reusser M,Giabbani E,Huynh A,Thürlemann C,Keller P,Alberio L

    更新日期:2014-03-20 00:00:00

  • Point mutations in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria (Günther's disease).

    abstract::Congenital erythropoietic porphyria (Günther's disease) is a rare disorder of heme biosynthesis inherited in an autosomal recessive fashion. The molecular abnormality responsible for the characteristic defect in uroporphyrinogen III synthase activity was investigated in two patients. For the first patient, complementa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deybach JC,de Verneuil H,Boulechfar S,Grandchamp B,Nordmann Y

    更新日期:1990-05-01 00:00:00

  • Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

    abstract::In this study, we randomly compared high doses of the tyrosine kinase inhibitor imatinib combined with reduced-intensity chemotherapy (arm A) to standard imatinib/hyperCVAD (cyclophosphamide/vincristine/doxorubicin/dexamethasone) therapy (arm B) in 268 adults (median age, 47 years) with Philadelphia chromosome-positiv...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2015-02-627935

    authors: Chalandon Y,Thomas X,Hayette S,Cayuela JM,Abbal C,Huguet F,Raffoux E,Leguay T,Rousselot P,Lepretre S,Escoffre-Barbe M,Maury S,Berthon C,Tavernier E,Lambert JF,Lafage-Pochitaloff M,Lhéritier V,Chevret S,Ifrah N,Dombr

    更新日期:2015-06-11 00:00:00

  • Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

    abstract::Doxorubicin, bleomycin, vinblastine sulfate, and dacarbazine (ABVD) is associated with severe toxicity in older patients, particularly from bleomycin-induced lung toxicity (BLT). Therefore, using bleomycin has been questioned in older Hodgkin lymphoma (HL) patients, especially in early-stage HL. We therefore analyzed ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-11-681064

    authors: Böll B,Goergen H,Behringer K,Bröckelmann PJ,Hitz F,Kerkhoff A,Greil R,von Tresckow B,Eichenauer DA,Bürkle C,Borchmann S,Fuchs M,Diehl V,Engert A,Borchmann P

    更新日期:2016-05-05 00:00:00

  • Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

    abstract::Twenty-two molecular diagnostic laboratories from 14 countries participated in a consortium study to estimate the impact of Factor VIII gene inversions in severe hemophilia A. A total of 2,093 patients with severe hemophilia A were studied; of those, 740 (35%) had a type 1 (distal) factor VIII inversion, and 140 (7%) ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Antonarakis SE,Rossiter JP,Young M,Horst J,de Moerloose P,Sommer SS,Ketterling RP,Kazazian HH Jr,Négrier C,Vinciguerra C,Gitschier J,Goossens M,Girodon E,Ghanem N,Plassa F,Lavergne JM,Vidaud M,Costa JM,Laurian Y,Lin

    更新日期:1995-09-15 00:00:00

  • A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.

    abstract::Adult T-cell leukemia (ATL) is neoplasm of the mature helper T lymphocytes and human T-cell lymphotropic virus type-I (HTLV-I) has been shown to be causative virus of ATL. Because HTLV-I integrates its provirus randomly into host chromosomal DNA, monoclonal integration of HTLV-I provirus indicates the clonal prolifera...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Takemoto S,Matsuoka M,Yamaguchi K,Takatsuki K

    更新日期:1994-11-01 00:00:00

  • Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia.

    abstract::The best initial therapy for elderly patients with chronic lymphocytic leukemia (CLL) has not yet been defined. We investigated the activity of lenalidomide as initial therapy for elderly patients with CLL. Sixty patients with CLL 65 years of age and older received treatment with lenalidomide orally 5 mg daily for 56 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-339077

    authors: Badoux XC,Keating MJ,Wen S,Lee BN,Sivina M,Reuben J,Wierda WG,O'Brien SM,Faderl S,Kornblau SM,Burger JA,Ferrajoli A

    更新日期:2011-09-29 00:00:00

  • Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial.

    abstract::Obinutuzumab is a type 2, glycoengineered, anti-CD20 antibody recently approved with chlorambucil for the initial therapy of chronic lymphocytic leukemia (CLL). In this nonrandomized, parallel-cohort, phase 1b, multicenter study, we explored the safety and preliminary efficacy of obinutuzumab-bendamustine (G-B) or obi...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2014-12-613570

    authors: Brown JR,O'Brien S,Kingsley CD,Eradat H,Pagel JM,Lymp J,Hirata J,Kipps TJ

    更新日期:2015-04-30 00:00:00

  • Hydrodynamic shear shows distinct roles for LFA-1 and Mac-1 in neutrophil adhesion to intercellular adhesion molecule-1.

    abstract::The binding of neutrophil beta2 integrin to intercellular adhesion molecule-1 (ICAM-1) expressed on the inflamed endothelium is critical for neutrophil arrest at sites of tissue inflammation. To quantify the strength and kinetics of this interaction, we measured the adhesion between chemotactically stimulated neutroph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Neelamegham S,Taylor AD,Burns AR,Smith CW,Simon SI

    更新日期:1998-09-01 00:00:00

  • Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment.

    abstract::Arsenic trioxide (As₂O₃) is a highly effective treatment for patients with refractory/relapsed acute promyelocytic leukemia (APL), but resistance to As₂O₃ has recently been seen. In the present study, we report the findings that 2 of 15 patients with refractory/relapsed APL treated with As₂O₃ were clinically As₂O₃ res...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-329433

    authors: Goto E,Tomita A,Hayakawa F,Atsumi A,Kiyoi H,Naoe T

    更新日期:2011-08-11 00:00:00

  • The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.

    abstract::The treatment of multiple myeloma has evolved significantly over the last decades from primarily alkylator-based chemotherapeutic agents with minimal efficacy to the introduction of more effective agents including immune modulators and proteasome inhibitors, which have changed the landscape of therapy for this disease...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-05-636357

    authors: Hoyos V,Borrello I

    更新日期:2016-09-29 00:00:00

  • Platelet interaction with subendothelial extracellular matrix: platelet-fibrinogen interactions are essential for platelet aggregation but not for the matrix-induced release reaction.

    abstract::Cultured endothelial cells produce an extracellular matrix (ECM) to which platelets adhere and spread, ultimately resulting in platelet aggregation, thromboxane B2 production, and serotonin release. We have investigated the role of fibrinogen binding to the platelet GPIIb/IIIa complex in these reactions by comparing n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Eldor A,Vlodavsky I,Martinowicz U,Fuks Z,Coller BS

    更新日期:1985-06-01 00:00:00